Product correctly added to cart.

discount label
Human IgA Antibody
View 3D

Biosynth logo

Human IgA Antibody

Ref. 3D-70-1105

1mg
267.00 €
Estimated delivery in United States, on Thursday 5 Dec 2024

Product Information

Name:
Human IgA Antibody
Description:

The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a powerful antituberculosis drug that falls under the category of rifamycins. It is highly effective in treating tuberculosis infections as it contains active compounds with bactericidal activity. Through its unique mechanism of action, this drug binds to DNA-dependent RNA polymerase, inhibiting bacterial growth and preventing transcription and replication.

In addition to its potent effects on tuberculosis, the 6-Fluoro-3-indoxyl-beta-D-galactopyranoside has been extensively studied using advanced techniques like patch-clamp technique on human erythrocytes. Its active form undergoes various metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid.

Furthermore, this drug specifically targets markers expressed at high levels in Mycobacter

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-70-1105 Human IgA Antibody

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".